In vivoT-cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non-malignant disease achieves engraftment with low incidence of graft vs. host disease-Reference-Cited by-同舟云学术

In vivoT-cell depletion using alemtuzumab in family and unrelated donor transplantation for pediatric non-malignant disease achieves engraftment with low incidence of graft vs. host disease

Published:2014-12-26 Issue:2 Volume:19 Page:211-218
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplantation

Author:

Saif M. A.¹,Borrill R.¹,Bigger B. W.²,Lee H.³,Logan A.³,Poulton K.³,Hughes S.⁴,Turner A. J.⁵,Bonney D. K.¹,Wynn R. F.¹

Affiliation:

1. Department of Blood and Marrow Transplant; Royal Manchester Children's Hospital; Manchester UK

2. Stem cell & Neurotherapies Laboratory; The University of Manchester; Manchester UK

3. Transplantation Laboratory; Manchester Royal Infirmary; Manchester UK

4. Department of Paediatric immunology; Royal Manchester Children's Hospital; Manchester UK

5. Department of Microbiology; Manchester Royal Infirmary; Manchester UK

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.12416/fullpdf

Reference29 articles.

1. Allogeneic stem cell transplantation for thalassemia major;Angelucci;Haematologica,2008

2. Allogeneic hematopoietic stem cell transplantation for sickle cell disease: The time is now;Hsieh;Blood,2011

3. Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy;Wynn;J Pediatr,2009

4. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: A report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry;Mitchell;Biol Blood Marrow Transplant,2013

5. Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single-center experience during 10 yr;Faraci;Pediatr Transplant,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an institutional protocol;Scientific Reports;2024-01-10

2. Immunotherapy with CD25/CD71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trial;Cytotherapy;2023-01

3. Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders;Blood Advances;2020-07-07

4. A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation for HHV8-Positive Castleman’s Disease with a Review of the Literature;Cell Transplantation;2020-01-01

5. Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA‐DPB1 typing;Pediatric Blood & Cancer;2019-12-18